Quantum量子訊息有限公司
← 最新全球產業報告

Bio-engineered Stent Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-01-27 · 151 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 5,747.60 Mn
2033 年預估規模
USD 9,960.3 Mn
年複合成長率 CAGR
8.7%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-01-27頁數 151報告編號 CMI2484

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Bio-engineered Stent Market, By Application Type (Coronary artery disease, Peripheral arterial disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, and Others), By Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting balloons), By Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), By Material Type (Metal-based and Polymer-based), By End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others. Market Dynamics Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths. Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S. However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent. Key features of the study • This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players • It profiles key players in the global bio-engineered stents market based on the following parameters – company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market Market Segmentation • By Application Type o Coronary artery disease o Peripheral arterial disease o Carotid Artery Disease o Renal Artery Stenosis o Abdominal Aortic Aneurysm o Thoracic Aortic Aneurysm o Others • By Product Type o Drug-eluting Stents o Bioabsorbable Stents o Drug-eluting balloons • By Mode of Delivery o Balloon-expandable Stents o Self-expanding Stents • By Material Type o Metal-based o Polymer-based • By End User o Hospitals & Cardiac Centers o Ambulatory Surgical Centers o Others • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players o Medtronic, plc. o Boston Scientific Corporation o Abbott Laboratories o Biotronik SE & Co. KG o Braun Melsungen AG o Terumo Corporation o MicroPort Scientific Corporation o Stentys Sao o Meril Life Sciences Pvt. Ltd o Vascular Concepts o L. Gore and Associates o R. Bard o Endologix, Inc. o Lombard Medical Technologies o Translumina GmbH o JOTEC GmbH
目錄 Table of Contents
Table of Contents 1. Research Objective and Assumption o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Application Type  Market Snippet, By Product Type  Market Snippet, By Material Type  Market Snippet, By Mode of Delivery  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Market Trends o Impact Analysis o Key Highlights o PEST Analysis o PORTER’s Analysis o Mergers and Acquisitions o Epidemiology 4. Global Bio-engineered Stent Market, By Application Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026– 2033  Segment Trends o Coronary artery disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Peripheral arterial disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Carotid Artery Disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Renal Artery Stenosis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Abdominal Aortic Aneurysm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Thoracic Aortic Aneurysm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 5. Global Bio-engineered Stent Market, By Product Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026– 2033  Segment Trends o Drug-eluting Stents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Bioabsorbable Stents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Drug-eluting balloons  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 6. Global Bio-engineered Stent Market, By Mode of Delivery, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026– 2033  Segment Trends o Balloon-expandable Stents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Self-expanding Stents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 7. Global Bio-engineered Stent Market, By Material Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026– 2033  Segment Trends o Metal-based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Polymer-based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 8. Global Bio-engineered Stent Market, By End User, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026– 2033  Segment Trends o Hospitals & Cardiac Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 9. Global Bio-engineered Stent Market, By Region, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2017–2033 o North America  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o U.S. o Canada o Latin America  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of APAC o Middle East  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Application Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Mode of Delivery, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Material Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)  Market Size and Forecast, By Country, 2026 – 2033, (USD Mn) o South Africa o Central Africa o North Africa 10. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profiles  Medtronic, plc. o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Boston Scientific Corporation o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Abbott Laboratories o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  BIOTRONIK SE & Co. KG o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  B. Braun Melsungen AG o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Terumo Corporation o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  MicroPort Scientific Corporation o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  STENTYS SA o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Meril Life Sciences Pvt. Ltd. o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Vascular Concepts o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  W. L. Gore and Associates o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  C. R. Bard o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Endologix, Inc. o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Lombard Medical Technologies o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  Translumina GmbH o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies  JOTEC GmbH o Company Overview o Type Portfolio o Financial Overview o Key Highlights o Market Strategies o Analyst Views 11. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Medtronic, plc.Boston Scientific CorporationAbbott LaboratoriesBiotronik SE & Co. KGBraun Melsungen AGTerumo CorporationMicroPort Scientific CorporationStentys SaoMeril Life Sciences Pvt. LtdVascular ConceptsL. Gore and AssociatesR. BardEndologix, Inc.Lombard Medical TechnologiesTranslumina GmbHJOTEC GmbH

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們